117 related articles for article (PubMed ID: 33414916)
1. Comparative analysis of target gene exon sequencing by cognitive technology using a next generation sequencing platform in patients with lung cancer.
Chen Y; Yan W; Xie Z; Guo W; Lu D; Lv Z; Zhang X
Mol Clin Oncol; 2021 Feb; 14(2):36. PubMed ID: 33414916
[TBL] [Abstract][Full Text] [Related]
2. Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing.
Patel NM; Michelini VV; Snell JM; Balu S; Hoyle AP; Parker JS; Hayward MC; Eberhard DA; Salazar AH; McNeillie P; Xu J; Huettner CS; Koyama T; Utro F; Rhrissorrakrai K; Norel R; Bilal E; Royyuru A; Parida L; Earp HS; Grilley-Olson JE; Hayes DN; Harvey SJ; Sharpless NE; Kim WY
Oncologist; 2018 Feb; 23(2):179-185. PubMed ID: 29158372
[TBL] [Abstract][Full Text] [Related]
3. Clinical insights into hematologic malignancies and comparative analysis of molecular signatures of acute myeloid leukemia in different ethnicities using an artificial intelligence offering.
Snowdon JL; Weeraratne D; Huang H; Brotman D; Xue S; Willis VC; Lee YK; Jeon K; Zang DY; Kim HJ; Kim HY; Han B; Kim M
Medicine (Baltimore); 2021 Dec; 100(51):e27969. PubMed ID: 34941036
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of curated contents by knowledge-based curation system in cancer clinical sequencing.
Sakai K; Takeda M; Shimizu S; Takahama T; Yoshida T; Watanabe S; Iwasa T; Yonesaka K; Suzuki S; Hayashi H; Kawakami H; Nonagase Y; Tanaka K; Tsurutani J; Saigoh K; Ito A; Mitsudomi T; Nakagawa K; Nishio K
Sci Rep; 2019 Aug; 9(1):11340. PubMed ID: 31383922
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Annotation Services for Next-Generation Sequencing in a Large-Scale Precision Oncology Program.
Katsoulakis E; Duffy JE; Hintze B; Spector NL; Kelley MJ
JCO Precis Oncol; 2020; 4():. PubMed ID: 32923873
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Clinical Genome Sequence Analysis by Watson for Genomics.
Itahashi K; Kondo S; Kubo T; Fujiwara Y; Kato M; Ichikawa H; Koyama T; Tokumasu R; Xu J; Huettner CS; Michelini VV; Parida L; Kohno T; Yamamoto N
Front Med (Lausanne); 2018; 5():305. PubMed ID: 30474028
[No Abstract] [Full Text] [Related]
7. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
[TBL] [Abstract][Full Text] [Related]
8. [Clinical sequencing in leukemia with the assistance of artificial intelligence].
Tojo A
Rinsho Ketsueki; 2017; 58(10):1913-1917. PubMed ID: 28978832
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of amplicon-based next-generation sequencing in cancer.
Chang F; Li MM
Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
[TBL] [Abstract][Full Text] [Related]
10. [Artificial intelligence-guided precision medicine in hematological disorders].
Yokoyama K
Rinsho Ketsueki; 2020; 61(5):554-563. PubMed ID: 32507824
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing of non-small cell lung cancer using a customized, targeted sequencing panel: Emphasis on small biopsy and cytology.
DiBardino DM; Rawson DW; Saqi A; Heymann JJ; Pagan CA; Bulman WA
Cytojournal; 2017; 14():7. PubMed ID: 28413430
[TBL] [Abstract][Full Text] [Related]
12. Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology.
Beg S; Bareja R; Ohara K; Eng KW; Wilkes DC; Pisapia DJ; Zoughbi WA; Kudman S; Zhang W; Rao R; Manohar J; Kane T; Sigouros M; Xiang JZ; Khani F; Robinson BD; Faltas BM; Sternberg CN; Sboner A; Beltran H; Elemento O; Mosquera JM
Transl Oncol; 2021 Jan; 14(1):100944. PubMed ID: 33190043
[TBL] [Abstract][Full Text] [Related]
13. An Accurate and Comprehensive Clinical Sequencing Assay for Cancer Targeted and Immunotherapies.
Cao J; Chen L; Li H; Chen H; Yao J; Mu S; Liu W; Zhang P; Cheng Y; Liu B; Hu Z; Chen D; Kang H; Hu J; Wang A; Wang W; Yao M; Chrin G; Wang X; Zhao W; Li L; Xu L; Guo W; Jia J; Chen J; Wang K; Li G; Shi W
Oncologist; 2019 Dec; 24(12):e1294-e1302. PubMed ID: 31409745
[TBL] [Abstract][Full Text] [Related]
14. Identification of Germline Mismatch Repair Gene Mutations in Lung Cancer Patients With Paired Tumor-Normal Next Generation Sequencing: A Retrospective Study.
Sun S; Liu Y; Eisfeld AK; Zhen F; Jin S; Gao W; Yu T; Chen L; Wang W; Chen W; Yuan M; Chen R; He K; Guo R
Front Oncol; 2019; 9():550. PubMed ID: 31297337
[No Abstract] [Full Text] [Related]
15. Comprehensive Molecular Characterization of Young Chinese Patients with Lung Adenocarcinoma Identified a Distinctive Genetic Profile.
Hou H; Zhu H; Zhao H; Yan W; Wang Y; Jiang M; Liu B; Liu D; Zhou N; Zhang C; Li P; Chang L; Guan Y; Wang Z; Zhang X; Li Z; Fang B; Zhang X
Oncologist; 2018 Sep; 23(9):1008-1015. PubMed ID: 29700208
[TBL] [Abstract][Full Text] [Related]
16. Identifying a wide range of actionable variants using capture-based ultra-deep targeted sequencing in treatment-naive patients with primary lung adenocarcinoma.
Chen L; Chen M; Lin J; Chen X; Yu X; Chen Z; Jin L
Int J Clin Exp Pathol; 2020; 13(3):525-535. PubMed ID: 32269691
[TBL] [Abstract][Full Text] [Related]
17. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
18. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
[TBL] [Abstract][Full Text] [Related]
19. Validity of an NGS-based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital.
Cao W; Yan C; Wang H; Tang T; Wang H; Liu D
Oncol Lett; 2019 Jun; 17(6):5425-5434. PubMed ID: 31186761
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of a cancer genomic profiling test using an in-house comprehensive targeted sequencing system.
Hayashi H; Tanishima S; Fujii K; Mori R; Okada C; Yanagita E; Shibata Y; Matsuoka R; Amano T; Yamada T; Yabe I; Kinoshita I; Komatsu Y; Dosaka-Akita H; Nishihara H
Cancer Sci; 2020 Oct; 111(10):3926-3937. PubMed ID: 32772458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]